Therapix Biosciences (TRPX) Prices 4.167M ADS Share Offering

Therapix Biosciences Ltd. (NASDAQ: TRPX) today announced the pricing of a public offering for the issuance of an aggregate of 4,166,668 units, each consisting of (i) one pre-funded warrant to purchase one American depositary share ("ADS") and (ii) one Series B warrant to purchase one ADS, at a purchase price of $0.2999 per unit. The Series B warrants will have an exercise price of $0.43 per ADS, will be exercisable upon issuance and will expire five years from the date of issuance.

The offering is expected to result in gross proceeds to Therapix of approximately $1.25 million. Therapix intends to use the net proceeds from the offering for working capital and general corporate purposes, and pursuing strategic opportunities, including business combination transactions.

The closing of the sale of the securities is expected to take place on April 3, 2020, subject to satisfaction of customary closing conditions.

Roth Capital Partners is acting as the sole agent for the offering on a "best efforts" basis.

You May Also Be Interested In

• ESS Tech closes $3.2M stock offering at $0.50 per share
• ESS Tech launches $3.2M stock offering at $0.50 per share
• Home Depot expands executive roles, grants $500K in restricted stock